Paules CI, Wang J, Tomashek KM, Bonnett T, et al. A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2. Ann Intern Med 2024 Feb 27. doi: 10.7326/M23-2593.
PMID: 38408357